Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

0610007N19Rik Inhibitors

The gene 0610007N19Rik, encoded within the mouse genome, plays a crucial role in the intricate web of cellular functions, though its precise biological significance remains an area of active research. The expression of genes like 0610007N19Rik is subject to a complex network of regulatory controls that ensure the appropriate levels of protein are produced according to the cell's needs. These regulatory mechanisms involve a multitude of processes, including transcriptional control, mRNA stabilization, and epigenetic modifications. To understand and potentially modulate the expression of 0610007N19Rik, scientists explore various chemicals that can exert influence over these regulatory pathways. For instance, compounds that interact with the epigenetic landscape of the gene can lead to alterations in expression without changing the underlying DNA sequence. DNA methylation inhibitors, such as 5-Azacytidine and Decitabine, can cause hypomethylation of gene promoter regions, potentially downregulating gene activity by changing the accessibility of the DNA to transcriptional machinery.

Furthermore, chemicals that target histone modification enzymes also present a method to decrease the expression of genes like 0610007N19Rik. Histone deacetylase inhibitors, such as Trichostatin A and Vorinostat, can lead to changes in chromatin structure, rendering the associated DNA less amenable to transcriptional activation. Other agents, like Mithramycin A, which binds to specific DNA sequences, can block the interaction between DNA and essential transcription factors, thus inhibiting the initiation of transcription. Additionally, transcription can be directly inhibited by compounds such as Actinomycin D, which intercalates into DNA and obstructs the advancement of RNA polymerase. Specific inhibitors of RNA polymerase II, like Alpha-amanitin and DRB (5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole), can also sharply reduce the synthesis of mRNA corresponding to 0610007N19Rik. While each of these chemicals provides an avenue to suppress the expression of 0610007N19Rik, their effects are subject to variability based on the cellular context and the presence of other regulatory factors. The use of these compounds in research settings offers valuable insights into gene expression modulation, enhancing our understanding of the genetic machinery that orchestrates the complex symphony of life at the molecular level.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Could demethylate promoter regions of the 0610007N19Rik gene, potentially leading to downregulation of its expression due to changes in transcriptional control.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

May inhibit histone deacetylase activity, leading to increased acetylation levels around the 0610007N19Rik locus, potentially resulting in the condensation of chromatin and decreased gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

By inhibiting DNA methyltransferases, it could specifically decrease methylation levels at the 0610007N19Rik promoter, and thereby reduce its transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

May block histone deacetylases, resulting in a chromatin structure around the 0610007N19Rik gene that is less conducive to transcription, leading to reduced expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Could bind selectively to the GC-rich sequences in the promoter of 0610007N19Rik, preventing the binding of specific transcription factors necessary for its transcription initiation.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Might bind to double-stranded DNA, particularly at the transcription start site of 0610007N19Rik, obstructing RNA polymerase action and thereby inhibiting gene expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

This compound selectively inhibits RNA polymerase II, which is critical for the transcription of mRNA, including that of 0610007N19Rik, leading to decreased levels of the protein.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Although primarily affecting bacterial RNA polymerase, in a research context, it could be used to decrease 0610007N19Rik expression in prokaryotic systems engineered to express eukaryotic genes.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Could selectively inhibit RNA Polymerase II at the 0610007N19Rik gene, resulting in a targeted decrease in transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

May inhibit the transcription of 0610007N19Rik by preventing the assembly of the transcription machinery at the gene′s promoter, leading to a decrease in mRNA synthesis.